EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evolutionary Trajectories and Reservoir Contributions to Viral Rebound Following Suppressive and Genome-Editing Therapies in HIV-1–Infected Humanized Mice

Daniel R. McLeod, Michael K. Chen, Sarah J. Thompson

International Journal of Information and Communication Technology Trends · 01.03.2026 · 6 (1) · 14-20

DOI: 10.71465/ijictt68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Information and Communication Technology Trends, online erschienen am 01.03.2026. Verfasst von Daniel R. McLeod und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral rebound following treatment interruption remains a major obstacle to durable HIV-1 remission, even after suppressive antiretroviral therapy or genome-editing interventions. This study examined the evolutionary dynamics and reservoir origins of rebound viruses in HIV-1–infected humanized mice subjected to combination antiretroviral therapy alone or combined with CRISPR-based proviral targeting. Humanized NOD/SCID/IL2Rγ-null mice (n = 50) were infected with HIV-1 and maintained under long-term viral suppression before treatment withdrawal. Plasma rebound viruses were longitudinally sampled over 6 weeks and analyzed using deep sequencing of env, gag, and pol regions. Viral genetic diversity, compartmentalization indices, and selection pressures were quantified and compared with proviral sequences recovered from lymphoid and non-lymphoid tissues prior to treatment interruption. Mice receiving combined therapy exhibited delayed rebound (median 18 vs. 9 days) and reduced peak viremia (2.3 log₁₀ lower, p < 0.01) compared with antiretroviral-only controls. Phylogenetic analyses revealed that rebound viruses originated from a limited subset of pre-existing proviral lineages, with reduced genetic diversity (Shannon index decrease of 41%) in the combined-treatment group. Notably, signatures of positive selection were enriched in envelope regions associated with immune evasion, whereas CRISPR target sites showed no evidence of adaptive escape mutations. These findings indicate that rebound viruses arise from genetically constrained reservoirs shaped by prior therapeutic pressure and highlight the importance of integrating evolutionary analyses when evaluating curative HIV-1 strategies.

Zitieren

APA

McLeod, D. R., Chen, M. K., & Thompson, S. J. (2026). Evolutionary Trajectories and Reservoir Contributions to Viral Rebound Following Suppressive and Genome-Editing Therapies in HIV-1–Infected Humanized Mice. International Journal of Information and Communication Technology Trends, 6(1), 14-20. https://doi.org/10.71465/ijictt68

Vancouver

McLeod DR, Chen MK, Thompson SJ. Evolutionary Trajectories and Reservoir Contributions to Viral Rebound Following Suppressive and Genome-Editing Therapies in HIV-1–Infected Humanized Mice. International Journal of Information and Communication Technology Trends. 2026;6(1):14-20. doi:10.71465/ijictt68

BibTeX
@article{McLeod2026,
  author = {McLeod, Daniel R. and Chen, Michael K. and Thompson, Sarah J.},
  title = {Evolutionary Trajectories and Reservoir Contributions to Viral Rebound Following Suppressive and Genome-Editing Therapies in HIV-1–Infected Humanized Mice},
  journal = {International Journal of Information and Communication Technology Trends},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {14--20},
  doi = {10.71465/ijictt68}
}
Kostenlos starten →